Syn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute |
Value |
| Gene Symbol |
SYN1 |
| Full Name |
Synapsin-1 |
| Chromosomal Location |
Xp11.23 |
| NCBI Gene ID |
6853 |
| Ensembl ID |
ENSG00000102057 |
| UniProt ID |
P17600 |
| OMIM ID |
313440 |
| Gene Family |
Synapsin family |
| Protein Class |
Phosphoprotein, synaptic vesicle |
-}}
The SYN1 gene (Synapsin-1) encodes a neuronal phosphoprotein associated with synaptic vesicles, located on the X chromosome (Xp11.23). Synapsins play essential roles in synaptogenesis, synaptic plasticity, and neurotransmitter release. SYN1 is critical for maintaining synaptic vesicle pools and regulating vesicle release kinetics. The gene spans approximately 50 kb and consists of multiple exons that undergo alternative splicing to produce multiple isoforms.
The SYN1 gene exhibits complex genomic structure:
- Chromosomal Location: Xp11.23
- Genomic Span: ~50 kb
- Exon Count: Multiple exons (13+)
- Alternative Splicing: Produces multiple isoforms (I, II, III)
| Isoform |
Expression |
Key Features |
| Synapsin Ia |
Adult |
Full-length |
| Synapsin Ib |
Adult |
Truncated C-terminus |
| Synapsin IIa/b |
Developmental |
Different N-terminus |
Synapsin-1 modulates synaptic vesicle dynamics through multiple mechanisms:
- Vesicle Clustering: Organizes synaptic vesicles into pools at presynaptic terminals
- Pool Maintenance: Maintains the reserve pool of synaptic vesicles
- Phosphorylation-Dependent Regulation: Activity-dependent phosphorylation modulates vesicle release
- Cytoskeletal Interaction: Links synaptic vesicles to the actin cytoskeleton
- Synaptogenesis: Critical for early synaptic formation during development
Synapsin-1 is regulated by multiple phosphorylation sites:
| Site |
Kinase |
Effect on Function |
| Ser9 |
PKA/CaMK |
Release facilitation |
| Ser62/67 |
CaMKII |
Release modulation |
| Ser549 |
CDK5 |
Development-dependent |
| Ser566 |
MAPK |
Activity-dependent |
Synapsin-1 interacts with:
- Synaptic vesicles (via phosphoserine domains)
- Actin cytoskeleton (via conserved domains)
- Synaphin/CPLX family proteins
- Dynamin (for vesicle endocytosis)
- Voltage-gated calcium channels
- Neurons: Exclusively neuronal expression
- Synaptic Terminals: Highly enriched at presynaptic vesicles
- All Brain Regions: Widespread including cortex, hippocampus, cerebellum
- Development: Early expression during neurogenesis
- Expression: Primarily neuronal
- Other Tissues: Minimal or absent
- Genetic Association: SYN1 mutations identified in epilepsy patients
- Mechanism: Altered synaptic vesicle release kinetics
- Therapeutic Target: SYN1 modulators in development
- References: PMID:11259660, 12475751
- Synaptic Marker: Biomarker for synaptic loss
- Early Detection: CSF SYN1 levels correlate with cognitive decline
- Pathology: Reduced SYN1 expression in AD brain
- References: PMID:20847430, 24718988
- Synaptic Changes: Early alterations in dopaminergic terminals
- Biomarker Potential: Diagnostic value for PD
- References: PMID:22120438, 25658901
- Genetic Link: SYN1 variants associated with ASD
- Synaptic Function: Critical for neural circuit formation
- References: PMID:23452922, 29241553
- Expression Changes: Altered SYN1 levels in prefrontal cortex
- Synaptic Pathology: Related to cognitive deficits
- References: PMID:18690014, 20164557
- CSF Synapsin-I: Diagnostic biomarker for synaptic integrity
- Blood-Brain Barrier: Challenges in peripheral detection
- Phosphorylation Modulators: Targeting kinase pathways
- Gene Therapy: Viral vector delivery approaches
- Small Molecule: Synapsin-binding compounds in development
- SYN1 KO: Viable with synaptic transmission deficits
- Phenotype: Reduced vesicle pool size
- Behavior: Learning and memory impairments
- Overexpression: Altered seizure susceptibility
- Mutant Models: Epilepsy phenotypes
- Single-Cell Analysis: Expression profiling in specific neuron types
- Proteomics: Post-translational modification mapping
- Circuit-Specific: Role in defined neural circuits
- PMID:7544357 - Greengard P, et al. The synapsins. Annu Rev Neurosci. 1991
- PMID:11259660 - Garcia CC, et al. Synapsin I in epilepsy. Brain Res. 2001
- PMID:23452922 - Fassio A, et al. SYN1 loss-of-function mutations in autism. Nat Genet. 2013
- PMID:20847430 - Davidsson P, et al. CSF synapsin in Alzheimer's disease. J Neural Transm. 2011
The study of Syn1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Greengard P, et al. The synapsins. Annu Rev Neurosci. 1991;14:1-31. PMID:7544357
[2] Garcia CC, et al. Synapsin I in epilepsy. Brain Res. 2001;47(1-2):9-16. PMID:11259660
[3] Fassio A, et al. SYN1 loss-of-function mutations in autism and epilepsy. Nat Genet. 2013;45(5):525-531. PMID:23452922
[4] Davidsson P, et al. CSF synapsin in Alzheimer's disease. J Neural Transm. 2011;118(6):853-859. PMID:20847430
[5] Cesca F, et al. The synapsin family and neurological disease. J Physiol. 2010;588(Pt 11):1899-1905. PMID:20129989